May 12, 2019 Parkinson’s Progression Markers Initiative (PPMI). Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson’s Disease
May 2, 2019 C-Path, CDISC Release Therapeutic Area Standard to Drive Research Forward for Clostridium Difficile Associated Diarrhea TUCSON, Ariz. and AUSTIN, May 2, 2019 — The Critical Path Institute (C-Path) and CDISC are pleased to announce the relea
May 1, 2019 Critical Path for Parkinson’s: Catalyzing Innovation for Parkinson’s Clinical Trials through Data Sharing and Regulatory Science. Stephenson D …et al. | American Academy of Neurology, Philadelphia, PA
April 24, 2019-April 25, 2019 Tenth Annual Patient-Reported Outcome Consortium Workshop WHAT: Tenth Annual Patient-Reported Outcome Consortium Workshop WHEN: April 24-25, 2019 WHERE: Sheraton Silver Sprin
April 24, 2019-April 25, 2019 Tenth Annual Patient-Reported Outcome Consortium Workshop April 24 – 25, 2019 Sheraton Silver Spring Hotel 8777 Georgia Avenue Silver Spring, MD 20910 On April 24-25, 2019 the Tenth Ann
April 16, 2019 C-Path, CDISC Develop Therapeutic Area Standard to Foster More Efficient and Meaningful Research for HIV TUCSON, Ariz. and AUSTIN, April 16, 2019 — The Critical Path Institute (C-Path) and CDISC are pleased to announce
April 9, 2019 C-Path Receives Qualification for the Asthma Daytime Symptom Diary (ADSD) and the Asthma Nighttime Symptom Diary (ANSD) TUCSON, Ariz., April 9, 2019 — Critical Path Institute’s (C-Path) Patient-Reported Outcome (PRO) Consortium announces U.S.
April 5, 2019 Muscular Dystrophy Association 2019 Clinical and Scientific Conference Jane Larkindale, Executive Director of D-RSC, attended the Muscular Dystrophy Association Clinical and Scientific Conference in Or
March 26, 2019 Critical Path Institute and Japan’s Pharmaceuticals and Medical Devices Agency Collaborate on First-of-its-Kind Biomarker Project Aim is to generate critical data to support safety decisions made in early-stage clinical trials TUCSON, Ariz., March 26, 2
March 21, 2019 C-Path Selects Global Regulatory Affairs Leader as New President and CEO TUCSON, Ariz., March 21, 2019 — After a worldwide search, the Critical Path Institute (C-Path) today announced it has appointed
